Related Experiment Video
Updated: Oct 16, 2025

Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling
Published on: August 3, 2018
The Regulatory Effect of MicroRNA-101-3p on Disc Degeneration by the STC1/VEGF/MAPK Pathway
Juehan Wang1, Leizhen Huang1, Xi Yang1
1Department of Orthopedic Surgery and Orthopedic Research Institute, West China Hospital, Sichuan University, No. 37 Guoxue Road, Chengdu, Sichuan, China.
Abstract:
Aims. Accumulating evidence reported that the microRNA (miRNA) took an important role in intervertebral disc degeneration (IDD). In this study, we revealed a novel miRNA regulatory mechanism in IDD. Main Methods. The miRNA microarray analyses of human degenerated and normal disc samples were employed to screen out the target miRNA. In vitro and in vivo experiments were conducted to verify the regulatory effect of miR-101-3p. Key Findings. The expression level of miR-101-3p was significantly decreased in the degenerated disc samples which were confirmed by qRT-PCR. Moreover, the miR-101-3p expression level was changed dynamically according to the disc degeneration grade. Upregulation of miR-101-3p expression level inhibited cell apoptosis. Furthermore, stanniocalcin-1 (STC1) was selected to be the target gene of miR-101-3p according to the bioinformatic algorithms. Mechanically, upregulation of miR-101-3p significantly decreased the expression of STC1, vascular endothelial growth factor (VEGF), and MAPK pathway expression levels. Therapeutically, in vivo experiment on IDD rat model illustrated that agomir-101-3p could effectively suspend IDD. Significance. Our findings demonstrated that miR-101-3p alleviated IDD process through the STC1/VEGF/MAPK pathway.
Insights
MicroRNA-101-3p, a key molecule, is downregulated in intervertebral disc degeneration (IDD). Restoring its levels inhibits apoptosis and alleviates IDD progression by targeting the STC1/VEGF/MAPK pathway.
Area of Science:
- Biomedical Research
- Molecular Biology
- Regenerative Medicine
Background:
- Intervertebral disc degeneration (IDD) is a significant cause of back pain, with microRNAs (miRNAs) implicated in its pathogenesis.
- Understanding novel miRNA regulatory mechanisms is crucial for developing effective IDD therapies.
Purpose of the Study:
- To identify and characterize the role of specific miRNAs in IDD.
- To elucidate the molecular mechanisms underlying miRNA-mediated regulation in IDD.
- To evaluate the therapeutic potential of targeting miRNAs for IDD treatment.
Main Methods:
- MicroRNA microarray analysis of human degenerated and normal disc samples.
- Quantitative real-time PCR (qRT-PCR) to validate miRNA expression.
- In vitro cell culture and in vivo rat models for functional studies.
- Bioinformatic analysis to predict and confirm miRNA-target interactions.
Main Results:
- miR-101-3p expression was significantly decreased in degenerated discs and correlated with IDD severity.
- Upregulation of miR-101-3p inhibited cell apoptosis and suppressed the expression of stanniocalcin-1 (STC1), vascular endothelial growth factor (VEGF), and the MAPK pathway.
- Administration of agomir-101-3p in an IDD rat model demonstrated a therapeutic effect in suspending disc degeneration.
Conclusions:
- miR-101-3p plays a protective role in intervertebral disc degeneration.
- The therapeutic potential of miR-101-3p warrants further investigation for IDD treatment.
- Targeting the STC1/VEGF/MAPK pathway via miR-101-3p offers a novel therapeutic strategy for IDD.
Related Concept Videos
MicroRNAs
Regulated Protein Degradation
TGF - β Signaling Pathway
Regulation of Angiogenesis and Blood Supply
MAPK Signaling Cascades
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

